SLI
2.022,65
PKT
+7,85
PKT
+0,39
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.04.14 | Novartis buy | UBS AG | |
| 23.04.14 | Novartis Hold | Deutsche Bank AG | |
| 22.04.14 | UBS buy | S&P Capital IQ | |
| 22.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.04.14 | UBS buy | Citigroup Corp. | |
| 17.04.14 | UBS Hold | Kelper Cheuvreux | |
| 17.04.14 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 17.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.04.14 | UBS buy | UBS AG | |
| 17.04.14 | Novartis buy | UBS AG | |
| 16.04.14 | Roche buy | Citigroup Corp. | |
| 16.04.14 | Nestlé Halten | Independent Research GmbH | |
| 16.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 16.04.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 16.04.14 | Roche overweight | Morgan Stanley | |
| 16.04.14 | Nestlé overweight | Morgan Stanley | |
| 16.04.14 | Nestlé Neutral | UBS AG | |
| 16.04.14 | Roche buy | UBS AG | |
| 16.04.14 | Roche overweight | Barclays Capital | |
| 15.04.14 | Nestlé Sell | S&P Capital IQ | |
| 15.04.14 | Roche kaufen | Independent Research GmbH | |
| 15.04.14 | Givaudan Outperform | Credit Suisse Group | |
| 15.04.14 | UBS Neutral | Goldman Sachs Group Inc. | |
| 15.04.14 | UBS buy | Goldman Sachs Group Inc. | |
| 14.04.14 | Roche buy | Jefferies & Company Inc. | |
| 14.04.14 | Novartis Hold | Jefferies & Company Inc. | |
| 14.04.14 | Givaudan overweight | JP Morgan Chase & Co. | |
| 14.04.14 | Nestlé overweight | JP Morgan Chase & Co. | |
| 14.04.14 | Givaudan Underweight | Barclays Capital | |
| 14.04.14 | Givaudan Underweight | Barclays Capital | |
| 14.04.14 | Givaudan buy | UBS AG | |
| 11.04.14 | Givaudan Neutral | Merrill Lynch & Co., Inc. | |
| 11.04.14 | Holcim buy | UBS AG | |
| 11.04.14 | Holcim buy | UBS AG | |
| 11.04.14 | UBS buy | UBS AG | |
| 11.04.14 | Roche buy | UBS AG | |
| 11.04.14 | UBS neutral | Deutsche Bank AG | |
| 11.04.14 | UBS buy | Deutsche Bank AG | |
| 10.04.14 | Holcim Neutral | Credit Suisse Group | |
| 10.04.14 | Holcim Neutral | Credit Suisse Group |